Division of Rheumatology, Allergy and Immunology
- Mildred Kwan, MD, PhD, and team received a Pfizer grant to address health disparities in antimicrobial stewardship.
Division of Pulmonary Diseases and Critical Care Medicine
- Scott Randell, PhD, was awarded a $2 million grant titled, “Validation of the RD-X19 COVID Treatment Device toward Regulatory Approval and Commercialization.”